|Articles|October 1, 2012
- Pharmaceutical Executive-10-01-2012
- Volume 0
- Issue 0
PE, October 2012 Cover Image
S
Advertisement
PE, October 2012 Cover Image
Articles in this issue
over 13 years ago
Pharmaceutical Executive Digital Edition - October 2012over 13 years ago
Lundbeck: Bidding for the Stars and Stripesover 13 years ago
The Drug Vote 2012over 13 years ago
Your Local Competitor: A Threat in Emerging Markets?over 13 years ago
Reforming Pharma Marketingover 13 years ago
Three Ways to the Futureover 13 years ago
Country Report: Turkeyover 13 years ago
Stem Cells: A Promise Deferred?over 13 years ago
Richard Bergström — Europe's Medicine ManNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
2
Parental Control: Why Pharma’s Strongest Asset May Be Its Parent Brand
3
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
4
Ketamine’s Regulatory Reckoning: From Rapid Growth to Enforcement
5